New preprint: GPCR Cryo-EM in Four Days Using Cell-Free Synthesis
Cell-free, detergent-free GPCR production expands structural access to difficult targets, including receptors without established ligands.
The challenge: obtaining GPCRs suitable for cryo-EM
High-resolution GPCR structure determination depends on more than protein yield. Researchers need purified, sufficiently homogeneous receptors that retain structural integrity throughout sample preparation. Conventional insect and mammalian expression workflows require weeks of optimization, while detergent extraction introduces further risks of misfolding, aggregation and loss of ligand binding.
A separate challenge applies to antagonist-bound and unliganded receptors. Most cryo-EM approaches stabilize GPCRs as complexes with signaling proteins, which requires an agonist. That route is unavailable for antagonist-bound states, and for orphan receptors there is no established ligand to work with at all.
A detergent-free route to structural-grade GPCRs
In a new study, researchers from Nuclera and a leading UK University combined cell-free protein synthesis with co-translational insertion into lipid nanodiscs to generate cryo-EM compatible GPCRs.
Using eProtein Discovery™, the team screened construct and nanodisc conditions, selected promising candidates for scale-up and assessed protein quality by fluorescence-detection size-exclusion chromatography (FSEC).
Combined with an engineered rigid structural aid (fiducial), this approach enabled the preparation of an antagonist-bound GPCR complex suitable for high-resolution cryo-EM.
![Cryo-EM structure of an antagonist-bound human A₂A receptor produced using cell-free protein synthesis and lipid nanodiscs. Figure credit: From Guilliam, et al., “Rapid Production and Cryo-EM Structure Determination of GPCR-Nanodisc Complexes via Cell-Free Synthesis. [Pre-print]” bioRxiv (2026). Used with permission.](data:image/svg+xml;base64,PHN2ZyB2aWV3Qm94PSIwIDAgMjIzNyAyMTU3IiB3aWR0aD0iMjIzNyIgaGVpZ2h0PSIyMTU3IiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg== "cryo-em-structure-human-a2a-receptor")
What the study demonstrated
- 3.38 Å cryo-EM structure: An antagonist-bound human adenosine A2A receptor (A2AR) complex produced entirely through cell-free synthesis, with a receptor architecture closely matching an insect-cell-derived reference.
- Four days from gene assembly to cryo-EM grids: Screening, scale-up, purification, quality assessment and grid vitrification were completed within four days for the demonstrated A2AR workflow.
- 12 additional GPCR targets: Receptors spanning Classes A, B and C—including six orphan GPCRs—were produced and purified in the unliganded state, with FSEC profiles supporting favourable biophysical quality.
Why this matters for GPCR discovery
The study provides experimental evidence that cell-free synthesis can deliver more than expressed receptor: it can generate nanodisc-embedded GPCR material suitable for downstream structural investigation.
For teams working on difficult GPCR targets, the approach offers a faster route to evaluating production conditions, assessing protein quality, and advancing candidates towards cryo-EM, without detergent extraction from cellular membranes.
Who should read this study?
- GPCR structural biologists: Exploring routes to homogeneous receptor preparations and high-resolution cryo-EM.
- Drug-discovery teams: Investigating antagonist-bound, unliganded and structurally challenging GPCR targets.
- Membrane-protein scientists: Evaluating alternative expression strategies, lipid environments and construct designs.
Dive Into the Study
Read the preprint paper: Rapid Production and Cryo-EM Structure Determination of GPCR-Nanodisc Complexes via Cell-Free Synthesis (BioRxiv, 2026)
